Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
The role of P-glycoprotein in drug resistance in multiple myeloma
Joseph Abraham
, Noha N. Salama
, Abdel Kareem Azab
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Cancer Biology
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output
:
Contribution to journal
›
Review article
›
peer-review
88
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The role of P-glycoprotein in drug resistance in multiple myeloma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Multiple Myeloma
100%
P-glycoprotein (P-gp)
100%
Drug Resistance
100%
Chemotherapy
14%
Bone Marrow
14%
Drug Transporters
14%
Inhibitory Effect
14%
Drug Use
14%
Drug Class
14%
Therapeutic Efficacy
14%
Protease Inhibitors
14%
Alkylating Agents
14%
Intracellular Accumulation
14%
Drug Therapy
14%
Multidrug Resistance Protein
14%
Immunomodulator
14%
Anthracyclines
14%
Plasma Cells
14%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Drug Resistance
100%
P-Glycoprotein
100%
Combination Therapy
14%
Malignant Neoplasm
14%
Chemotherapy
14%
Pharmacotherapy
14%
Antiinfective Agent
14%
Alkylating Agent
14%
Effusion
14%
Anthracycline
14%
Immunomodulating Agent
14%
Proteasome Inhibitor
14%
Immunology and Microbiology
Drug Resistance
100%
Multiple Myeloma
100%
P-Glycoprotein
100%
Proteasome
14%
Upregulation
14%
Immunomodulating Drugs
14%
Immunoglobulin Producing Cell
14%
Drug Therapy
14%